AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35367144 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Distraction Intervention
Number of subjects: 139
Study 34144683 — intervention group
Group type: EXPERIMENTAL
Intervention: remimazolam besylate
Number of subjects: 0
Study 34144683 — intervention group
Group type: COMPARATOR
Intervention: propofol
Number of subjects: 0
Study 32142388 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus condition (jumping towards a physical cone)
Number of subjects: 0
Study 32142388 — intervention group
Group type: COMPARATOR
Intervention: Imagery condition (jumping towards an imagined cone)
Number of subjects: 0
Study 33052397 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group
Number of subjects: 405
Study 33052397 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 405
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker measurement of tau
Number of subjects: 168
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker measurement of GFAP
Number of subjects: 168
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: NFL measured at discharge
Number of subjects: 168
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: GFAP measured 48 hours after induction
Number of subjects: 168
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: GFAP measured at discharge
Number of subjects: 168
Study 34130895 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE
Number of subjects: 168
Study 33349849 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically decreased serum ACE levels (using genetic variants from the ORIGIN trial)
Number of subjects: 4147
Study 33349849 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically decreased serum ACE levels (using genetic variants from the AGES cohort)
Number of subjects: 4147
Study 36352558 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session, clinician-delivered screening and brief intervention (SBI)
Number of subjects: 143
Study 36352558 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 143
Study 34900443 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy+Exercise (MT+Exercise) Group
Number of subjects: 58
Study 34900443 — intervention group
Group type: COMPARATOR
Intervention: Exercise Group
Number of subjects: 58
Study 35078205 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful (nociceptive stimulation)
Number of subjects: 36
Study 35078205 — intervention group
Group type: EXPERIMENTAL
Intervention: Painless (non‐nociceptive stimulation)
Number of subjects: 36
Study 35078205 — intervention group
Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 36
Study 34023199 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model established using five features
Number of subjects: 108
Study 34023199 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination model incorporating radiomics signature with two clinical biomarkers
Number of subjects: 108
Study 33299555 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT/LCT/OO/FO IVLE
Number of subjects: 12
Study 33299555 — intervention group
Group type: COMPARATOR
Intervention: Standard IVLE
Number of subjects: 12
Study 33754803 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter AVR with AF at discharge
Number of subjects: 2663
Study 33754803 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter AVR with SR/AF
Number of subjects: 2663
Study 33754803 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical AVR with AF at discharge
Number of subjects: 2663
Study 33754803 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter AVR and Surgical AVR with AF at discharge
Number of subjects: 2663
Study 33754803 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter AVR cohort
Number of subjects: 2663
Study 32925344 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed EEG-guided anesthetic management to keep the Patient State Index (PSI) above 35
Number of subjects: 204
Study 32925344 — intervention group
Group type: COMPARATOR
Intervention: Standard care (EEG data blinded from clinicians)
Number of subjects: 204
Study 32925344 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed EEG-guided anesthetic management
Number of subjects: 204
Study 32925344 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 204
Study 33291998 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback on behaviours that elicit positive emotions (PA)
Number of subjects: 72
Study 33291998 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring only
Number of subjects: 72
Study 34482102 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib 12 mg combined with camrelizumab 200 mg every 3 weeks
Number of subjects: 0
Study 34482102 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib 8 mg combined with camrelizumab 200 mg every 3 weeks
Number of subjects: 0
Study 34482102 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with brain metastasis
Number of subjects: 0
Study 34482102 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ECOG 0 and 1
Number of subjects: 0
Study 35704398 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load blood flow restriction (LLBFR)
Number of subjects: 14
Study 35704398 — intervention group
Group type: COMPARATOR
Intervention: Low-load nonBFR (LL)
Number of subjects: 14
Study 34176622 — intervention group
Group type: EXPERIMENTAL
Intervention: Pair-housing (PH)
Number of subjects: 24
Study 34176622 — intervention group
Group type: COMPARATOR
Intervention: Individual housing (IH)
Number of subjects: 24
Study 35803626 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly community-based testing for anaemia
Number of subjects: 3800
Study 35803626 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory group education sessions
Number of subjects: 3800
Study 35803626 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos
Number of subjects: 3800
Study 35803626 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention (all components)
Number of subjects: 3800
Study 35803626 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3800
Study 34729992 — intervention group
Group type: EXPERIMENTAL
Intervention: bioresorbable-polymer DES
Number of subjects: 206
Study 34729992 — intervention group
Group type: EXPERIMENTAL
Intervention: durable-polymer DES
Number of subjects: 206
Study 34729992 — intervention group
Group type: COMPARATOR
Intervention: high-dose acetylcholine (10−4 mol/L)
Number of subjects: 206
Study 34729992 — intervention group
Group type: COMPARATOR
Intervention: bioactive DES
Number of subjects: 206
Study 34729992 — intervention group
Group type: COMPARATOR
Intervention: low-dose acetylcholine
Number of subjects: 206
Study 34729992 — intervention group
Group type: COMPARATOR
Intervention: high-dose acetylcholine
Number of subjects: 206
Study 36271420 — intervention group
Group type: EXPERIMENTAL
Intervention: JX-594 combined with metronomic cyclophosphamide (arm 1)
Number of subjects: 20
Study 36271420 — intervention group
Group type: COMPARATOR
Intervention: Metronomic cyclophosphamide (arm 2)
Number of subjects: 20
Study 32743690 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 134
Study 32743690 — intervention group
Group type: COMPARATOR
Intervention: Gadobutrol
Number of subjects: 134
Study 33542928 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodom-assisted urokinase treatment (PAUT)
Number of subjects: 261
Study 33542928 — intervention group
Group type: COMPARATOR
Intervention: Syringe-assisted urokinase treatment (SAUT)
Number of subjects: 261
Study 33542928 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (TT)
Number of subjects: 261
Study 34294478 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonavalent vaccine HPV types
Number of subjects: 80
Study 36065821 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of NOAC (≤4 days)
Number of subjects: 888
Study 36065821 — intervention group
Group type: COMPARATOR
Intervention: Delayed initiation of NOAC (5-10 days)
Number of subjects: 888
Study 33914068 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence estimation using two immunoassays
Number of subjects: 0
Study 33914068 — intervention group
Group type: COMPARATOR
Intervention: Comparison with case-based surveillance data
Number of subjects: 0
Study 34310714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 25
Study 34310714 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 25
Study 33129360 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal cannula (HFNC)
Number of subjects: 0
Study 33129360 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 0
Study 33129360 — intervention group
Group type: EXPERIMENTAL
Intervention: Health economic analysis
Number of subjects: 0
Study 34910390 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mesometrial resection (TMMR) and therapeutic lymphadenectomy (tLNE)
Number of subjects: 116
Study 32619694 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta rTMS (6 Hz)
Number of subjects: 20
Study 32619694 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha rTMS (10 Hz)
Number of subjects: 20
Study 33669552 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature walk
Number of subjects: 13
Study 33669552 — intervention group
Group type: COMPARATOR
Intervention: Urban walk
Number of subjects: 13
Study 33678687 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Coping Skills Training (PCST)
Number of subjects: 164
Study 33678687 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 33123819 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 40
Study 33123819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35785574 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (one trial of 20 min, 1 mA, cathodal electrodes placed bilaterally on the FPT areas)
Number of subjects: 22
Study 35785574 — intervention group
Group type: COMPARATOR
Intervention: Sham group (30 s tDCS treatment)
Number of subjects: 22
Study 35785574 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 22
Study 34120651 — intervention group
Group type: EXPERIMENTAL
Intervention: remogliflozin etabonate 500 mg BID with metformin 2000 mg
Number of subjects: 50
Study 34120651 — intervention group
Group type: EXPERIMENTAL
Intervention: remogliflozin etabonate 750 mg BID with metformin 2000 mg
Number of subjects: 50
Study 34120651 — intervention group
Group type: COMPARATOR
Intervention: Placebo BID with metformin 2000 mg
Number of subjects: 50
Study 32443082 — intervention group
Group type: EXPERIMENTAL
Intervention: T. vaginalis positive cases (n = 45)
Number of subjects: 789
Study 32443082 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 789
Study 32443082 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant girls with T. vaginalis (n = 26)
Number of subjects: 789
Study 35646196 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-assisted CPR
Number of subjects: 28
Study 35646196 — intervention group
Group type: COMPARATOR
Intervention: Instructor-assisted CPR
Number of subjects: 28
Study 32465759 — intervention group
Group type: EXPERIMENTAL
Intervention: Sternal-sparing approach
Number of subjects: 161
Study 32465759 — intervention group
Group type: COMPARATOR
Intervention: Median sternotomy
Number of subjects: 161
Study 33098117 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk eye drops
Number of subjects: 312
Study 33098117 — intervention group
Group type: COMPARATOR
Intervention: Sodium azulene sulphonate hydrate 0.02% ophthalmic solution
Number of subjects: 312
Study 33397563 — intervention group
Group type: EXPERIMENTAL
Intervention: TWIN high
Number of subjects: 726
Study 33397563 — intervention group
Group type: EXPERIMENTAL
Intervention: TWIN low
Number of subjects: 726
Study 33397563 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐BP
Number of subjects: 726
Study 33397563 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐ATRA
Number of subjects: 726
Study 33397563 — intervention group
Group type: COMPARATOR
Intervention: VC
Number of subjects: 726
Study 34953663 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddled bathing
Number of subjects: 60
Study 34953663 — intervention group
Group type: COMPARATOR
Intervention: Traditional tub bathing
Number of subjects: 60
Study 32279363 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ program executed twice a week for 20 weeks
Number of subjects: 71
Study 32279363 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular warm-up)
Number of subjects: 71
Study 35935332 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive therapy and full perfusion therapy (combined with conventional therapy)
Number of subjects: 70
Study 35935332 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 70
Study 33251988 — intervention group
Group type: EXPERIMENTAL
Intervention: Running (RUN)
Number of subjects: 64
Study 33251988 — intervention group
Group type: EXPERIMENTAL
Intervention: Elliptical training (ELIP)
Number of subjects: 64
Study 33251988 — intervention group
Group type: COMPARATOR
Intervention: Resting recovery (REST)
Number of subjects: 64
Study 35735106 — intervention group
Group type: EXPERIMENTAL
Intervention: NTS training program implemented during the second week of a 2-week rotation.
Number of subjects: 16
Study 35735106 — intervention group
Group type: EXPERIMENTAL
Intervention: NTS training program
Number of subjects: 16
Study 35735106 — intervention group
Group type: COMPARATOR
Intervention: Control group (learners and teachers deciding together what should be learnt)
Number of subjects: 16
Study 32757218 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month personalized treatment considering LPR characteristics at impedance-pH monitoring
Number of subjects: 127
Study 36266483 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine injection method (LIM) during ESD
Number of subjects: 50
Study 36266483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 50
Study 33484307 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS group (additional PDS cerclage with an 8-loop configuration over the AC joint)
Number of subjects: 30
Study 33484307 — intervention group
Group type: COMPARATOR
Intervention: No-PDS group (bi-cortical CC-ligament reconstruction only)
Number of subjects: 30
Study 33484307 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PDS and No-PDS)
Number of subjects: 30
Study 33484307 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS group
Number of subjects: 30
Study 32227773 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Jiaji acupoints (EX-B2) plus moxibustion and intermediate frequency
Number of subjects: 140
Study 32227773 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional acupuncture)
Number of subjects: 140
Study 35289266 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based exercise (VRBE) intervention, 45 minutes per session, 2 days a week for 12 weeks
Number of subjects: 38
Study 35289266 — intervention group
Group type: COMPARATOR
Intervention: Control group managed with supportive measures
Number of subjects: 38
Study 33468598 — intervention group
Group type: EXPERIMENTAL
Intervention: Video interpretation
Number of subjects: 50
Study 33468598 — intervention group
Group type: COMPARATOR
Intervention: Telephone interpretation
Number of subjects: 50
Study 35725851 — intervention group
Group type: EXPERIMENTAL
Intervention: Hernial sac ligation (HL)
Number of subjects: 93
Study 35725851 — intervention group
Group type: COMPARATOR
Intervention: Non-ligation/invagination (non-HL)
Number of subjects: 93
Study 34636521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectric Muscle Activation (BMA) system (Accufit)TM; treatment regimen: four 30-minute sessions
Number of subjects: 29
Study 32101630 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle development program conducted over 7 months with group activities once a month and daily individual activities.
Number of subjects: 0
Study 32101630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 0
Study 35085524 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 768
Study 35085524 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 768
Study 33181142 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% IDL lotion applied over 2 weeks
Number of subjects: 0
Study 33181142 — intervention group
Group type: COMPARATOR
Intervention: Ethyl linoleate/oleate
Number of subjects: 0
Study 36078584 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-G)
Number of subjects: 0
Study 36078584 — intervention group
Group type: COMPARATOR
Intervention: High-intensity interval training (HIIT-G)
Number of subjects: 0
Study 32443357 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation
Number of subjects: 60
Study 32443357 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation + norepinephrine
Number of subjects: 60
Study 32443357 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation + norepinephrine + ulinastatin (20,000 U/h)
Number of subjects: 60
Study 32443357 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 60
Study 33461385 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) 4.5 g
Number of subjects: 15
Study 33461385 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (placebo) 4.5 g
Number of subjects: 15
Study 33245242 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 33245242 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 33245242 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose corticosteroid therapies
Number of subjects: 0
Study 33710427 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal uterosacral ligament suspension (USLS)
Number of subjects: 186
Study 32711471 — intervention group
Group type: EXPERIMENTAL
Intervention: Searching CENTRAL
Number of subjects: 247
Study 34952812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation for 8 weeks, weekly 20-minute sessions with voluntary contraction attempts during the last 10 minutes of each session.
Number of subjects: 64
Study 34952812 — intervention group
Group type: COMPARATOR
Intervention: Control group received no intervention.
Number of subjects: 64
Study 34826341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure goal of <120 mm Hg)
Number of subjects: 9361
Study 34826341 — intervention group
Group type: COMPARATOR
Intervention: Adjudicated MCI
Number of subjects: 9361
Study 32334166 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary and reactive responses to climate-related hazards
Number of subjects: 0
Study 32334166 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening adaptive infrastructure (physical and informational)
Number of subjects: 0
Study 35997037 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD) by nonexpert operators
Number of subjects: 251
Study 35997037 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD) by nonexpert operators
Number of subjects: 251
Study 34185627 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenarios set in the present
Number of subjects: 188
Study 34185627 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenarios set in the past
Number of subjects: 188
Study 35235550 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccine (Gardasil or Gardasil 9)
Number of subjects: 273
Study 35235550 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC) - Avaxim, a hepatitis A vaccine
Number of subjects: 273
Study 32556348 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolling cane (Wheeleo®)
Number of subjects: 32
Study 32556348 — intervention group
Group type: COMPARATOR
Intervention: Classical quadripod cane
Number of subjects: 32
Study 36115814 — intervention group
Group type: EXPERIMENTAL
Intervention: INOCA patients (n=476)
Number of subjects: 3612
Study 36115814 — intervention group
Group type: COMPARATOR
Intervention: Moderate or severe ischemia
Number of subjects: 3612
Study 36115814 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 3612
Study 32960320 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT)
Number of subjects: 10
Study 32380954 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft Seal® (Portex®)
Number of subjects: 80
Study 32380954 — intervention group
Group type: EXPERIMENTAL
Intervention: AuraOnce™ (Ambu®)
Number of subjects: 80
Study 32380954 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA‐Classic™ (Teleflex®)
Number of subjects: 80
Study 32380954 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal™ (Teleflex®)
Number of subjects: 80
Study 32380954 — intervention group
Group type: COMPARATOR
Intervention: Maximum recommended volume
Number of subjects: 80
Study 35816815 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HP)
Number of subjects: 60
Study 35816815 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein diet (NP)
Number of subjects: 60
Study 35816815 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional meal replacement (MR)
Number of subjects: 60
Study 35816815 — intervention group
Group type: COMPARATOR
Intervention: All groups (HP, NP, MR)
Number of subjects: 60
Study 34183800 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief interventions that increase subjective understanding of algorithmic decision processes
Number of subjects: 2699
Study 34183800 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic skin cancer detection app
Number of subjects: 2699
Study 32833136 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin in combination with trastuzumab and pertuzumab
Number of subjects: 50
Study 32781441 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% 1-RM bench press
Number of subjects: 20
Study 32781441 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% 1-RM squat (squat-70%)
Number of subjects: 20
Study 32781441 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% 1-RM squat (squat-80%)
Number of subjects: 20